[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.159.129.152. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Citations 0
Letters
April 25, 2007

Clopidogrel and Long-term Outcomes After Drug-Eluting Stent Implantation

Author Affiliations
 

Letters Section Editor: Robert M. Golub, MD, Senior Editor.

JAMA. 2007;297(16):1769-1771. doi:10.1001/jama.297.16.1769-a

To the Editor: Dr Eisenstein and colleagues1 assessed the association between long-term clopidogrel use and clinical outcomes after drug-eluting stent (DES) implantation. The authors suggested that all patients with DES should continue to take clopidogrel for at least 12 months after intervention and possibly indefinitely. However, some methodological issues need to be considered.

First Page Preview View Large
First page PDF preview
First page PDF preview
×